HSBC Holdings
ATYR

HSBC Holdings’s aTyr Pharma ATYR Stock Holding History

HSBC Holdings’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9K Buy
18,214
+2,078
+13% +$1.75K ﹤0.01% 2864
2025
Q4 		$12.1K Sell
16,136
-3
-0% -$2 ﹤0.01% 2903
2025
Q3 		$11.8K Sell
16,139
-8,445
-34% -$38.3K ﹤0.01% 2680
2025
Q2 		$128K Buy
+24,584
New +$96.7K ﹤0.01% 2800

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings's ATYR Position: Q1 2026 in Review

HSBC Holdings increased its aTyr Pharma (ATYR) stake by 13% in Q1 2026, buying an estimated $1.75K and bringing the position to 18,214 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2864.

HSBC Holdings first reported a position in ATYR in Q2 2025 and has held it in 4 quarters since. The position peaked at $128K in Q2 2025. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

  • HSBC Holdings held 18,214 shares of aTyr Pharma worth $13.9K as of Q1 2026.
  • HSBC Holdings bought 2,078 aTyr Pharma shares in Q1 2026, an estimated $1.75K.
  • aTyr Pharma made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2864 holding.
  • HSBC Holdings first reported a position in aTyr Pharma in Q2 2025 and has held it in 4 quarters since.
  • HSBC Holdings's aTyr Pharma position peaked at $128K in Q2 2025.
  • 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.